William Denny

Device Project Leader, Device Development & Commercialisation Novartis

Conference Day One

Wednesday, May 6th, 2020

1:10 PM Case Study: Engineering Combination Products Towards a New Path with Insulin Biosimilars

• Look at the commercialisation of biosimilar versions on insulins, used to treat patients with type 1 and type 2 diabetes 
• Discuss the challenges associated with developing the combination products
• Specifically review how to make the combination products affordable for patients

Check out the incredible speaker line-up to see who will be joining William.

Download The Latest Agenda